Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II...

by Jayne D.R.
Published 2023

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease

by Marco, H, Smith, R.M, Jones, R.B, Guerry, M.-J, Catapano, F, Burns, S, Chaudhry, A.N, Smith, K.G, Jayne, D.R
Published 2020

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases

by Flint S.M., Jovanovic V., Teo B.W., Mak A., Thumboo J., McKinney E.F., Lee J.C., MacAry P., Kemeny D.M., Jayne D.R.W., Fong K.Y., Lyons P.A., Smith K.G.C.
Published 2018

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease

by McKinney, E.F., Lyons, P.A., Carr, E.J., Hollis, J.L., Jayne, D.R.W., Willcocks, L.C., Koukoulaki, M., Brazma, A., Jovanovic, V., Kemeny, D.M., Pollard, A.J., MacAry, P.A., Chaudhry, A.N., Smith, K.G.C.
Published 2014